Page 12 - Pharming Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pharming Group reports third quarter 2023 financial results Third quarter 2023 revenues increased 23% to US$66.7 million, compared to the third quarter 2022, driven by RUCONEST® revenue and the U.S. commercial launch of Joenja®Nine month year to date 2023 revenues increased 9% to US$164.1 million, compared to nine month year to date 2022RUCONEST® revenues increased 11% in the third quarter 2023 to US$60.2 million, compared to the third quarter 2022, and increased 18% compared to the second quart

Pharming Group N.V. (PHARM.AMS) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Pharming Group N.V. | Euronext Amsterdam: PHARM | Euronext Amsterdam

U.S. stocks traded lower, with the Nasdaq Composite falling more than 90 points on Thursday. Here are some big stocks bucking the trend and recording gains in today’s session.

Leiden, The Netherlands, October 12, 2023: Pharming Group N.V. confirms it will report its preliminary third quarter 2023 financial results, for the period ended September 30, on Thursday, October...

Leiden, The Netherlands, October 12, 2023: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its...